3645 results for «569»

Filter By

3645 results

Innovative solutions in complex coronary lesions - Part 1

18 May 2022 – From EuroPCR 2022

Consult this session to discover some innovative solutions in complex coronary lesions, such as: revascularisation for a case with ULMCA and RCA calcification CTO, stentless treatment for left main quadrifurcation lesion, OCT-guided PCI with intravascular lithotripsy in a calcified SVG, and more!

Innovative solutions in complex coronary lesions

Innovative solutions in complex coronary lesions - Part 2

18 May 2022 – From EuroPCR 2022

Consult this session to learn about innovative solutions in complex coronary lesions, thanks to a variety of cases such as: PCI in a patient with absolute contraindication to contrast administration, another kiss in bifurcation, unexplained hypotension and a new mass, and more!

Innovative solutions in complex coronary lesions

Innovative solutions in complex coronary lesions - Part 3

18 May 2022 – From EuroPCR 2022

Watch these videos to discover some innovative solutions in complex coronary lesions, thanks to a selection of cases: a 27-year-old woman with STEMI and multiple culprit lesions, an unusual communication between aorta and the heart, CTO RCA done with retrograde approach with reverse CART technique, and more!

Innovative solutions in complex coronary lesions

Treatment of small vessel disease - To stent or not to stent?

07 Oct 2022 – From AICT-AsiaPCR 2022

Consult this session if you want to learn the tips and tricks to perform a small vessel disease intervention and to discuss the pros and cons of treating small vessel disease with DCB and/or DES.

Treatment of small vessel disease - To stent or not to stent?

OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease

04 Nov 2021

Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG
Didn’t find what you were looking for?